Kozak & Associates »

Crispr Therapeutics shares owned by Kozak & Associates

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Kozak & Associates from 13F filings

Historical chart of Kozak & Associates investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Kozak & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Kozak & Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.6k 26 63.42
2023-09-30 $1.1k 26 43.08
2023-06-30 $1.5k 26 56.27
2023-03-31 $1.2k 26 45.23
2022-12-31 $999 26 38.46
2022-09-30 $2.0k 26 76.92
2022-06-30 $2.0k 26 76.92
2022-03-31 $2.0k 26 76.92
2021-12-31 $2.0k 26 76.92
2021-09-30 $2.0k 26 76.92